AGM/EGMJun 11, 2026, 04:37 PM
Pacira Stockholders Elect All 3 Director Nominees; Reject 2011 Stock Plan
AI Summary
Pacira BioSciences held its 2026 Annual Meeting, where stockholders elected all three of the company's director nominees and approved the Amended and Restated 2014 Employee Stock Purchase Plan, authorizing an additional 800,000 shares. However, stockholders rejected the Amended and Restated 2011 Stock Incentive Plan. The board also restructured committee compositions, and KPMG LLP was ratified as the independent auditor.
Key Highlights
- All three of Pacira's director nominees (Christie, Hirawat, Wiggans) were elected to the Board.
- Stockholders approved the Amended and Restated 2014 Employee Stock Purchase Plan, increasing authorized shares by 800,000.
- Stockholders rejected the Amended and Restated 2011 Stock Incentive Plan with 18,405,754 votes against.
- KPMG LLP was ratified as the independent registered public accounting firm with 32,908,044 votes For.
- The advisory vote to approve executive compensation passed with 19,513,224 votes For.
- The Board restructured committee compositions, including Alethia Young as Audit Committee Chair.
Price Impact
More from PCRX